New imaging tool could sharpen spinal surgery precision
NCT ID NCT07416565
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study will test a new imaging tool called the ATEC IntraOperative Alignment (IOA) Platform in 40 adults undergoing spinal deformity surgery. The tool helps surgeons see and measure spinal alignment during the operation, potentially allowing for more precise corrections. Researchers will compare its accuracy to standard X-rays and see how well it predicts final alignment after surgery.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- ATEC IntraOperative Alignment (IOA) Imaging Platform
- What this could lead to
- If successful, this tool could help surgeons make more accurate spinal corrections during surgery, potentially improving outcomes for patients with spinal deformities.
- What could go wrong
- This is a small, early-stage study with only 40 participants, so results may not apply to everyone. The tool is meant to assist, not replace, standard care, and its benefits over current methods are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL DEFORMITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spine alignment may hold key to pelvic floor health
- Spine surgery breakthrough? simple drug pour may cut blood loss and transfusions
- Spinal implants pass 24-Month safety check in 77 patients
- AI reads your back: no X-Ray needed for scoliosis?
- Spray-on drug may cut blood loss in major spine surgery
- Spine surgery infection breakthrough? vancomycin powder tested in new trial